Technical Chemicals & Products Inc looks at financial options & gets new CEO (Chief Executive Officer)
This article was originally published in Clinica
The point-of-care diagnostics company, Technical Chemicals & Products (TCPI), has hired investment bankers to look at options for its future at the same time as implementing changes in its top management. It has retained Janssen/Meyers Associates to explore opportunities, including "possible equity or debt offerings and potential mergers, acquisitions and other strategic transactions".
You may also be interested in...
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.